Introduction: dose adjustment of antibiotic drugs is fundamental in critically ill patients and newborns, who may experience inadequate exposure of these drugs due to different pharmacokinetics (PK) and pharmacodynamics (PD) compared to other patients. Despite the increasing use of microsampling devices such as Dried Blood Spot (DBS) and Volumetric Absorptive Microsampling (VAMS) in paediatric clinical practice, little is reported on the comparison between these two devices in terms of β-lactam antibiotics quantification. Methods: a method using high-performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS) for the simultaneous determination of amoxicillin, ampicillin, meropenem and cefadroxil from both DBS and V...
Introduction - Clinical pharmacokinetic studies of antibiotics can establish evidence-based dosing r...
IntroductionTherapeutic drug monitoring (TDM) has been shown to be clinically beneficial for critica...
Miltefosine is an oral agent against the neglected tropical disease leishmaniasis, which is mostly e...
Introduction: dose adjustment of antibiotic drugs is fundamental in critically ill patients and newb...
Introduction: dose adjustment of antibiotic drugs is fundamental in critically ill patients and newb...
Introduction: dose adjustment of antibiotic drugs is fundamental in critically ill patients and newb...
Introduction: dose adjustment of antibiotic drugs is fundamental in critically ill patients and newb...
Objectives: Conduction of pharmacokinetic (PK) study in pediatric patients is challenging due to blo...
Background: Volumetric absorptive microsamples (VAMS) can support pharmacokinetic /pharmacodynamic s...
Rational dosing of antibiotics in neonates should be based on pharmacokinetic (PK) parameters assess...
textabstractRational dosing of antibiotics in neonates should be based on pharmacokinetic (PK) param...
Rational dosing of antibiotics in neonates should be based on pharmacokinetic (PK) parameters assess...
ABSTRACT: Introduction: Clinical pharmacokinetic studies of antibiotics can establish evidence-based...
Rational dosing of antibiotics in neonates should be based on pharmacokinetic (PK) parameters assess...
Rational dosing of antibiotics in neonates should be based on pharmacokinetic (PK) parameters assess...
Introduction - Clinical pharmacokinetic studies of antibiotics can establish evidence-based dosing r...
IntroductionTherapeutic drug monitoring (TDM) has been shown to be clinically beneficial for critica...
Miltefosine is an oral agent against the neglected tropical disease leishmaniasis, which is mostly e...
Introduction: dose adjustment of antibiotic drugs is fundamental in critically ill patients and newb...
Introduction: dose adjustment of antibiotic drugs is fundamental in critically ill patients and newb...
Introduction: dose adjustment of antibiotic drugs is fundamental in critically ill patients and newb...
Introduction: dose adjustment of antibiotic drugs is fundamental in critically ill patients and newb...
Objectives: Conduction of pharmacokinetic (PK) study in pediatric patients is challenging due to blo...
Background: Volumetric absorptive microsamples (VAMS) can support pharmacokinetic /pharmacodynamic s...
Rational dosing of antibiotics in neonates should be based on pharmacokinetic (PK) parameters assess...
textabstractRational dosing of antibiotics in neonates should be based on pharmacokinetic (PK) param...
Rational dosing of antibiotics in neonates should be based on pharmacokinetic (PK) parameters assess...
ABSTRACT: Introduction: Clinical pharmacokinetic studies of antibiotics can establish evidence-based...
Rational dosing of antibiotics in neonates should be based on pharmacokinetic (PK) parameters assess...
Rational dosing of antibiotics in neonates should be based on pharmacokinetic (PK) parameters assess...
Introduction - Clinical pharmacokinetic studies of antibiotics can establish evidence-based dosing r...
IntroductionTherapeutic drug monitoring (TDM) has been shown to be clinically beneficial for critica...
Miltefosine is an oral agent against the neglected tropical disease leishmaniasis, which is mostly e...